Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FK91X
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,886
Award facts
- Contract value 100% obligated
- $13,886.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order on September 25, 2025, by the Defense Logistics Agency (DLA) for the supply of Nexplanon 68 mg implants. The contract carries a ceiling value of $13,886.00 and is scheduled for completion by October 17, 2025. This delivery order was issued without a set-aside designation, allowing the company to compete on an open basis despite its small business status. The place of performance is located in Park Ridge, Illinois, where DMS Pharmaceutical Group maintains its primary operations.
This award is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This master contract enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting medical supply needs of military health facilities worldwide, including prescription medications, biologics, and medical consumables. The Nexplanon implant, a contraceptive device, represents one component of the extensive pharmaceutical portfolio DMS Pharmaceutical Group supplies to Department of Defense healthcare sites, positioning the company as a critical supplier within the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB25FK91X?
SPE2DB25FK91X was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FK91X worth?
The government has obligated $13,886 on SPE2DB25FK91X.
Is contract SPE2DB25FK91X an order under another contract?
Yes. SPE2DB25FK91X is a delivery order under SPE2DB20D9202, an indefinite delivery contract.
Was contract SPE2DB25FK91X competed?
The extent of competition for SPE2DB25FK91X was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award